Protagonist Therapeutics Jumps 5.3% After Barclays Maintains Overweight
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Protagonist Therapeutics shares surged 5.3% Wednesday to $138.27 after Barclays upgraded its price target by 26.9%, reflecting growing confidence in the biotechnology company’s prospects. The stock gained on volume of 478,669 shares as…






